Assessment of the test characteristics of an instant anti-CCP2 test compared to the anti-CCP2 elisa in serum

Assessment of the test characteristics of an instant anti-CCP2 test compared to the anti-CCP2 elisa in serum - Test characteristics of an instant anti-CCP2 test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30010

Enrollment

160

Registered

2006-08-24

Start date

2006-09-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arthritis Reumatoid Arthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Rheumatoid arthritis informed consent given Aerea of Nijmegen Previous Anti-CCP2 status determined

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Results from the anti-CCP2 quicktest with capillary and venous blood are compared to each other and to the anti-CCP2 elisa in serum using dichotomeous and trichotomeous distributions (negatief, weakly positive and positive (33 table) or positive and negative (22) table). Testcharacteristics are decribed using sensitivity, specificity, positive and negative predictive value.	—

Secondary

Measure	Time frame
Pragmatic aspects including needed time, feasability and the percentage of failed tests are described qualitatively and quantitatively.	—

Countries

Netherlands

Outcome results